The agreement covers 18 countries in Latin America, including Brazil, Mexico, Colombia, and Argentina. Separately, Moderna announced a distribution service agreement with Adium Pharma, a Montevideo, Uruguay-based bio/pharmaceutical company, to support the commercialization of Spikevax across Latin America.

In addition, the Thermo Fisher will provide inspection, labeling and final packaging services. Thermo Fisher will now provide dedicated capacity for a range of aseptic fill–finish services, including lyophilized and liquid filling. This included the scale-up of aseptic fill–finish services and packaging of Moderna’s COVID-19 vaccine. Over the past several years (as reported on February 23, 2022), Thermo Fisher has been partnering with Moderna to support its development pipeline with both clinical research and contract manufacturing services. Moderna and Thermo Fisher Scientific have formed a 15-year pact for large-scale US manufacturing of Spikevax, Moderna’s COVID-19 vaccine, and other investigational mRNA medicines in Moderna’s pipeline. Moderna, Thermo Fisher in Mfg Pact for COVID-19 Vaccine Manufacturing and supply of COVID-19 vaccines and drugs The latest on COVID-19 vaccines/drugs and manufacturing from Moderna, AstraZeneca, Sanofi, GSK, Thermo Fisher Scientific, Novavax, Valneva, Dow, Sartorius, Südpack, USP, and the World Health Organization.

Adium pharma uruguay